![Stephen Webster](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Webster
Directeur/Membre du Conseil chez
CULLINAN THERAPEUTICS, INC.
Fortune : - $ au 31/08/2026
Profil
Mr. Stephen W.
Webster is an Independent Director at Eloxx Pharmaceuticals, Inc., an Independent Director at Cullinan Therapeutics, Inc. and an Independent Director at NextCure, Inc. He is on the Board of Directors at Eloxx Pharmaceuticals, Inc., Imvax, Inc., Cullinan Therapeutics, Inc., NextCure, Inc., Nuron Biotech, Inc. and Spark Therapeutics UK Ltd. Mr. Webster was previously employed as an Independent Director by Nexoplex Bio, Inc., an Independent Director by Cullinan Oncology LLC, a Chairman by TCR2 Therapeutics, Inc., a Member-Supervisory Board by Nabriva Therapeutics GmbH, an Independent Director by Nabriva Therapeutics Plc, a Chief Financial & Accounting Officer by Spark Therapeutics, Inc., an Independent Director by Viking Therapeutics, Inc., a Chief Financial Officer & Senior Vice President by Optimer Pharmaceuticals LLC, an Independent Director by HearUSA, Inc., a Chief Financial Officer & Senior Vice President by Adolor Corp., a Managing Director-Investment Banking Division by Broadpoint Securities, Inc., a Managing Director-Healthcare Investment Banking by Broadpoint.Gleacher Securities, a President & Chief Executive Officer by Neuronyx, Inc., and a Director-Investment Banking Division by PaineWebber, Inc. He also served on the board at Triplet Therapeutics, Inc. and Life Sciences Pennsylvania.
He received his undergraduate degree from Dartmouth College and an MBA from The Wharton School of the University of Pennsylvania.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 | |
NEXTCURE, INC. -.--% | 18/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| 08/06/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Postes actifs de Stephen Webster
| Sociétés | Poste | Début |
|---|---|---|
| NEXTCURE, INC. | Directeur/Membre du Conseil | 01/04/2019 |
| CULLINAN THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/09/2020 |
| ELOXX PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 27/05/2026 |
ImVax, Inc.
 ImVax, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Directeur/Membre du Conseil | 06/09/2023 |
Spark Therapeutics UK Ltd.
 Spark Therapeutics UK Ltd. Medical/Nursing ServicesHealth Services Provides health care services | Directeur/Membre du Conseil | 03/08/2016 |
Nuron Biotech, Inc.
 Nuron Biotech, Inc. BiotechnologyHealth Technology Markets and develops vaccines for the prevention and treatment of infectious diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Stephen Webster
| Sociétés | Poste | Fin |
|---|---|---|
| GRITSTONE BIO, INC. | Directeur/Membre du Conseil | 04/04/2025 |
| TCR2 THERAPEUTICS INC. | Président | 01/06/2023 |
| VIKING THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/01/2020 |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Stephen Webster
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
96
Relations au 1er degré
24
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
HearUSA, Inc.
 HearUSA, Inc. Medical DistributorsDistribution Services Distributes audio-logical products and provides hearing impaired services | Distribution Services |
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Neuronyx, Inc.
 Neuronyx, Inc. Medical SpecialtiesHealth Technology Develops and distributes bone marrow derived stem cells | Health Technology |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Broadpoint.Gleacher Securities
 Broadpoint.Gleacher Securities Investment Banks/BrokersFinance Provides brokerage services | Finance |
PaineWebber, Inc.
 PaineWebber, Inc. Investment Banks/BrokersFinance Provides stock brokerage and asset management services | Finance |
Broadpoint Securities, Inc.
 Broadpoint Securities, Inc. Investment Banks/BrokersFinance Provides broker-dealer and investment banking services | Finance |
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products | Health Technology |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Health Technology |
Life Sciences Pennsylvania
 Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Provides consulting services to biosciences industry | Commercial Services |
Nuron Biotech, Inc.
Nuron Biotech, Inc. BiotechnologyHealth Technology Markets and develops vaccines for the prevention and treatment of infectious diseases | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Viking Therapeutics, Inc.
 Viking Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for metabolic and endocrine disorders | Health Technology |
Gritstone bio, Inc.
 Gritstone bio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer | Health Technology |
NextCure, Inc.
 NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
Nabriva Therapeutics Plc
 Nabriva Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the research, development, and commercialization of novel anti-infective agents | Health Technology |
ImVax, Inc.
ImVax, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Cullinan Oncology LLC
 Cullinan Oncology LLC Financial ConglomeratesFinance Provides investment services for cancer treatments | Finance |
Eloxx Pharmaceuticals, Inc.
 Eloxx Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that discovers and develops therapeutics to treat cystic fibrosis, inherited retinal disorders and other diseases | Health Technology |
Spark Therapeutics UK Ltd.
Spark Therapeutics UK Ltd. Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
Triplet Therapeutics, Inc.
 Triplet Therapeutics, Inc. Medical/Nursing ServicesHealth Services Develops therapy for huntington's , myotonic dystrophy, spin cerebellar ataxias and repeated expansion diseases | Health Services |
Cullinan Oncology, Inc.
 Cullinan Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
